These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Patients' experiences with participating in a team-based person-centred intervention for patients at risk of or diagnosed with COPD in general practice. Kolltveit BH; Graue M; Borge CR; Frisk B Pilot Feasibility Stud; 2023 Sep; 9(1):164. PubMed ID: 37749601 [TBL] [Abstract][Full Text] [Related]
4. A comparison of approaches for combining predictive markers for personalised treatment recommendations. Pierce M; Emsley R Trials; 2021 Jan; 22(1):20. PubMed ID: 33407760 [TBL] [Abstract][Full Text] [Related]
5. Biomarker-Guided Non-Adaptive Trial Designs in Phase II and Phase III: A Methodological Review. Antoniou M; Kolamunnage-Dona R; Jorgensen AL J Pers Med; 2017 Jan; 7(1):. PubMed ID: 28125057 [TBL] [Abstract][Full Text] [Related]
6. The impact of a personalised action plan delivered at discharge to patients with COPD on readmissions: a pilot study. Hegelund A; Andersen IC; Andersen MN; Bodtger U Scand J Caring Sci; 2020 Dec; 34(4):909-918. PubMed ID: 31865631 [TBL] [Abstract][Full Text] [Related]
7. Progress and pitfalls with the use of image-guided personalised approaches in lymphoma. Illidge TM; Phillips EH Br J Radiol; 2021 Nov; 94(1127):20210609. PubMed ID: 34520671 [TBL] [Abstract][Full Text] [Related]
8. Dysfunction in the Cystic Fibrosis Transmembrane Regulator in Chronic Obstructive Pulmonary Disease as a Potential Target for Personalised Medicine. Carrasco-Hernández L; Quintana-Gallego E; Calero C; Reinoso-Arija R; Ruiz-Duque B; López-Campos JL Biomedicines; 2021 Oct; 9(10):. PubMed ID: 34680554 [TBL] [Abstract][Full Text] [Related]
9. Biomarker-guided trials: Challenges in practice. Antoniou M; Kolamunnage-Dona R; Wason J; Bathia R; Billingham C; Bliss JM; Brown LC; Gillman A; Paul J; Jorgensen AL Contemp Clin Trials Commun; 2019 Dec; 16():100493. PubMed ID: 31788574 [TBL] [Abstract][Full Text] [Related]
10. A multi-center randomized, controlled, open-label trial evaluating the effects of eosinophil-guided corticosteroid-sparing therapy in hospitalised patients with COPD exacerbations - The CORTICO steroid reduction in COPD (CORTICO-COP) study protocol. Sivapalan P; Moberg M; Eklöf J; Janner J; Vestbo J; Laub RR; Browatzki A; Armbruster K; Wilcke JT; Seersholm N; Weinreich UM; Titlestad IL; Andreassen HF; Ulrik CS; Bødtger U; Nielsen TL; Hansen EF; Jensen JUS BMC Pulm Med; 2017 Aug; 17(1):114. PubMed ID: 28810909 [TBL] [Abstract][Full Text] [Related]
12. Personalised therapeutic approaches to glioblastoma: A systematic review. Mowforth OD; Brannigan J; El Khoury M; Sarathi CIP; Bestwick H; Bhatti F; Mair R Front Med (Lausanne); 2023; 10():1166104. PubMed ID: 37122327 [TBL] [Abstract][Full Text] [Related]
13. The value of personalised risk information: a qualitative study of the perceptions of patients with prostate cancer. Han PK; Hootsmans N; Neilson M; Roy B; Kungel T; Gutheil C; Diefenbach M; Hansen M BMJ Open; 2013 Sep; 3(9):e003226. PubMed ID: 24038007 [TBL] [Abstract][Full Text] [Related]
14. Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease. Lenferink A; Brusse-Keizer M; van der Valk PD; Frith PA; Zwerink M; Monninkhof EM; van der Palen J; Effing TW Cochrane Database Syst Rev; 2017 Aug; 8(8):CD011682. PubMed ID: 28777450 [TBL] [Abstract][Full Text] [Related]
15. Prostate cancer androgen receptor splice variant 7 biomarker study - a multicentre randomised feasibility trial of biomarker-guided personalised treatment in patients with advanced prostate cancer (the VARIANT trial) study protocol. Clark E; Morton M; Sharma S; Fisher H; Howel D; Walker J; Wood R; Hancock H; Maier R; Marshall J; Bahl A; Crabb S; Jain S; Pedley I; Jones R; Staffurth J; Heer R BMJ Open; 2019 Dec; 9(12):e034708. PubMed ID: 31857319 [TBL] [Abstract][Full Text] [Related]
16. The path to personalised medicine in COPD. Agusti A Thorax; 2014 Sep; 69(9):857-64. PubMed ID: 24781218 [TBL] [Abstract][Full Text] [Related]
17. Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management. Woodruff PG; Agusti A; Roche N; Singh D; Martinez FJ Lancet; 2015 May; 385(9979):1789-1798. PubMed ID: 25943943 [TBL] [Abstract][Full Text] [Related]
18. Personalised care planning for adults with chronic or long-term health conditions. Coulter A; Entwistle VA; Eccles A; Ryan S; Shepperd S; Perera R Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD010523. PubMed ID: 25733495 [TBL] [Abstract][Full Text] [Related]
19. Activating primary care COPD patients with multi-morbidity through tailored self-management support. Ansari S; Hosseinzadeh H; Dennis S; Zwar N NPJ Prim Care Respir Med; 2020 Apr; 30(1):12. PubMed ID: 32245961 [TBL] [Abstract][Full Text] [Related]